Condition
AMD - Age-Related Macular Degeneration clinical trials and research
As of November 12, 2026, Find a Trial lists 5 AMD - Age-Related Macular Degeneration clinical trials that are recruiting, at sites in 4 countries (most in Italy (2), United States (1), China (1)). By phase: Phase 1 (1), Phase 1/2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 4Countries
Newest AMD - Age-Related Macular Degeneration clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| How macular neovascular membrane type affects recovery after pneumatic displacement for macular hemorrhage | — | Trento, Trento | Recruiting | Feb 23, 2026 |
| Transplanting hiPSC-derived RPE Cells for Advanced AMD | Phase 1/2 | Nanjing, Jiangsu | Recruiting | Feb 18, 2026 |
| ABF-101 single and multiple ascending dose safety test in healthy adults and people with AMD | Phase 1 | Dallas, Texas | Recruiting | Jan 9, 2026 |
| My Eyes, My Light — community eye screening in Char Fasson | — | Char Fasson, Bhola | Recruiting | Aug 22, 2025 |
| Evaluating visual rehabilitation's effects on anxiety and depression in patients with AMD | — | Rome, Italy | Recruiting | Apr 2, 2025 |
All recruiting trials (5)
-
How macular neovascular membrane type affects recovery after pneumatic displacement for macular hemorrhage
This project will test if the type of macular neovascular membrane predicts vision and retinal recovery after pneumatic displacement in Caucasian patients aged 50 and over with submacular hemorrhage from AMD.
-
Transplanting hiPSC-derived RPE Cells for Advanced AMD
This trial tests whether transplanting lab-made retinal pigment epithelium cells can help people aged 50–85 with late-stage AMD see if their condition improves or stabilizes.
-
ABF-101 single and multiple ascending dose safety test in healthy adults and people with AMD
This study will test whether ABF-101 is safe, well tolerated, and how it behaves in the body in healthy adults and in people with age-related macular degeneration.
-
My Eyes, My Light — community eye screening in Char Fasson
This project tests whether a community-based screening program can find treatable eye problems in people aged 35 and older who live in Char Fasson, Bangladesh.
-
Evaluating visual rehabilitation's effects on anxiety and depression in patients with AMD
This study is testing whether a visual rehabilitation program can help reduce anxiety and depression in people with advanced age-related macular degeneration.
Related topics
Quick answers
How many AMD - Age-Related Macular Degeneration clinical trials are recruiting right now?
5, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in Italy (2 trials), United States (1 trial), China (1 trial), Bangladesh (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.